Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate the Safety”

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT07318909
What this trial is testing

To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria

Who this might be right for
Phenylketonuria (PKU)
Gritgen Therapeutics Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46
Testing effectiveness (Phase 2)Study completedNCT00622193
What this trial is testing

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Helsinn Therapeutics (U.S.), Inc 228
Not applicableLooking for participantsNCT06993493
What this trial is testing

Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Disease
Beijing Boren Hospital 12
Early research (Phase 1)Study completedNCT01205321
What this trial is testing

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 19
Early research (Phase 1)Study completedNCT05328726
What this trial is testing

Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Gan and Lee Pharmaceuticals, USA 24
Testing effectiveness (Phase 2)Ended earlyNCT04545385
What this trial is testing

Test if TEV-48574 is Effective in Relieving Asthma

Who this might be right for
Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 65
Large-scale testing (Phase 3)Ended earlyNCT00338585
What this trial is testing

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Who this might be right for
Arterial Occlusive Diseases
ARCA Biopharma, Inc. 300
Very early researchEnded earlyNCT06110208
What this trial is testing

Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML

Who this might be right for
Acute Myeloid Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 3
Large-scale testing (Phase 3)Study completedNCT00648908
What this trial is testing

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 269
Early research (Phase 1)WithdrawnNCT05999708
What this trial is testing

A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline
Testing effectiveness (Phase 2)Looking for participantsNCT07811908
What this trial is testing

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT04967508
What this trial is testing

Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisModerate to Severe Plaque Psoriasis
Samsung Bioepis Co., Ltd. 503
Large-scale testing (Phase 3)Study completedNCT02214225
What this trial is testing

Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

Who this might be right for
Influenza, Human
Seqirus 3,484
Early research (Phase 1)Study completedNCT02582840
What this trial is testing

The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 42
Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Early research (Phase 1)UnknownNCT01615250
What this trial is testing

Implantation of Peripheral Stem Cells in Patient With Ischemic Cardiomyopathy

Who this might be right for
Heart Failure
Odessa National Medical University 50
Not applicableStudy completedNCT07154797
What this trial is testing

Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma

Who this might be right for
CataractOcular HypertensionGlaucoma
SpyGlass Pharma, Inc. 24
Large-scale testing (Phase 3)Ended earlyNCT03283397
What this trial is testing

A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bosnalijek D.D 301
Testing effectiveness (Phase 2)Study completedNCT05052697
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

Who this might be right for
Influenza, Human
Pfizer 1,158
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation